Trapianto di Fegato Per Colangiocarcinoma (CCA) Ilare in Associazione a Radio e Chemioterapia Neoadiuvante
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Percentage of patients free of disease at 24 months post-transplant
24 months
No
Umberto Cillo, MD
Study Chair
Azienda Ospedaliera di Padova
Italy: Ethics Committee
2372P
NCT01549795
January 2012
Name | Location |
---|